World Hepatitis Summit

November 1-3, 2017
São Paulo, Brazil
Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, presented on the DNDi strategy on access to hepatitis C treatment.

AASLD The Liver Meeting®

October 20-24, 2017
Washington DC, USA
Isabelle Andrieux-Meyer, Paediatric HIV/HCV Team Leader at DNDi, spoke at the HCV public health symposium.

Daiichi Sankyo announces collaborative research on drugs for neglected diseases

[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.

IMTechCon 2017

October 4-6, 2017
Chandigarh, India
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.

2016 in Review

Our staff, partners, and stakeholders share their highlights from 2016.